{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:50:52Z","timestamp":1761630652749},"reference-count":5,"publisher":"Hindawi Limited","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":853,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatol Ther"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1111\/j.1529-8019.2013.01549.x","type":"journal-article","created":{"date-parts":[[2013,6,6]],"date-time":"2013-06-06T14:20:54Z","timestamp":1370528454000},"page":"257-259","source":"Crossref","is-referenced-by-count":16,"title":["Omalizumab in chronic urticaria: a retrospective series of 15 cases"],"prefix":"10.1155","volume":"26","author":[{"given":"Miquel","family":"Armengot-Carbo","sequence":"first","affiliation":[{"name":"Department of Dermatology; Hospital Arnau de Vilanova; Valencia; Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Velasco-Pastor","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Hospital Arnau de Vilanova; Valencia; Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Rodrigo-Nicolas","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Hospital Arnau de Vilanova; Valencia; Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Pont-Sanjuan","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Hospital Arnau de Vilanova; Valencia; Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Quecedo-Estebanez","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Hospital Arnau de Vilanova; Valencia; Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"Gimeno-Carpio","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Hospital Arnau de Vilanova; Valencia; Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2013,6,6]]},"reference":[{"key":"10.1111\/j.1529-8019.2013.01549.x-BIB0001|dth1549-cit-0001","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jaci.2011.06.010","article-title":"A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria","volume":"128","author":"Saini","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1529-8019.2013.01549.x-BIB0002|dth1549-cit-0002","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1476-7961-9-2","article-title":"Down regulation of the high-affinity IgE receptor associated with successful treatment of chronic idiopathic urticaria with omalizumab","volume":"9","author":"Saavedra","year":"2011","journal-title":"Clin Mol Allergy"},{"key":"10.1111\/j.1529-8019.2013.01549.x-BIB0003|dth1549-cit-0003","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/j.1398-9995.2009.02178.x","article-title":"EAACI\/GA(2)LEN\/EDF\/WAO guideline: management of urticaria","volume":"64","author":"Zuberbier","year":"2009","journal-title":"Allergy"},{"key":"10.1111\/j.1529-8019.2013.01549.x-BIB0004|dth1549-cit-0004","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jaci.2008.07.006","article-title":"Treatment of chronic autoimmune urticaria with omalizumab","volume":"122","author":"Kaplan","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1529-8019.2013.01549.x-BIB0005|dth1549-cit-0005","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jaci.2011.04.038","article-title":"Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase","volume":"128","author":"Maurer","year":"2011","journal-title":"J Allergy Clin Immunol"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1529-8019.2013.01549.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1529-8019.2013.01549.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:00:11Z","timestamp":1671818411000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1529-8019.2013.01549.x"}},"subtitle":["Omalizumab in chronic urticaria"],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,5]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1529-8019.2013.01549.x","relation":{},"ISSN":["1396-0296"],"issn-type":[{"value":"1396-0296","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}